Gene Therapy and Genomic Editing

By WIRB-Copernicus Group
Published: June 2018

Recent advances in recombinant DNA technology—especially “CRISPR” techniques—have raised public interest in the potential for genome editing to change the future of medicine.

To learn more, register for our free white paper Gene Therapy and Genomic Editing.

Please enter in your information below. Fields with an * are required.

Please enter a valid email address to receive an email with a link to download the white paper.   

The WIRB-Copernicus Group® (WCG) is the world’s largest and most trusted provider of regulatory and ethical review services for human research.